Athyrium Capital Management, LP Biora Therapeutics, Inc. Transaction History

Athyrium Capital Management, LP

$3.2 Million
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.13 - $12.03 $1.63 Million - $150 Million	12,506,250 Added 41.89%	42,362,097 $5.51 Million
Q4 2021 Feb 14, 2022	SELL	$1.35 - $4.89 $8.83 Million - $32 Million	-6,541,060 Reduced 17.97%	29,855,847 $62.4 Million
Q2 2021 Aug 16, 2021	BUY	$2.11 - $4.93 $19.8 Million - $46.2 Million	9,365,281 Added 34.65%	36,396,907 $130 Million
Q4 2020 Feb 16, 2021	BUY	$3.27 - $9.48 $88.4 Million - $256 Million	27,031,626 New	27,031,626 $144 Million

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Athyrium Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athyrium Capital Management, LP with notifications on news.